StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 Jul 2026 07:59:56 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday CorMedix (CRMD) PT Lowered to $13 at RBC Capital http://www.streetinsider.com/Analyst+PT+Change/CorMedix+%28CRMD%29+PT+Lowered+to+%2413+at+RBC+Capital/26738656.html RBC Capital analyst Leonid Timashev lowered the price target on CorMedix (NASDAQ: CRMD) to $13.00 (from $14.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/CorMedix+%28CRMD%29+PT+Lowered+to+%2413+at+RBC+Capital/26738656.html Tue, 07 Jul 2026 07:59:56 -0400 CRMD Form 8-K CorMedix Inc. For: Jun 29 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+29/26728441.html si-local-file:///var/storage/secattach/20260702/26728441.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+29/26728441.html Thu, 02 Jul 2026 16:32:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 29 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+29/26728441.html si-local-file:///var/storage/secattach/20260702/26728441.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+29/26728441.html Thu, 02 Jul 2026 16:32:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 25 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+25/26716754.html si-local-file:///var/storage/secattach/20260701/26716754.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+25/26716754.html Wed, 01 Jul 2026 07:14:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 25 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+25/26716754.html si-local-file:///var/storage/secattach/20260701/26716754.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+25/26716754.html Wed, 01 Jul 2026 07:14:00 -0400 CRMD O.08513169 Form S-8 POS CorMedix Inc. http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CorMedix+Inc.++++++++++++++++++++++++/26692901.html si-local-file:///var/storage/secattach/20260625/26692901.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CorMedix+Inc.++++++++++++++++++++++++/26692901.html Thu, 25 Jun 2026 16:36:00 -0400 CRMD O.08513169 Form S-8 POS CorMedix Inc. http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CorMedix+Inc.++++++++++++++++++++++++/26692901.html si-local-file:///var/storage/secattach/20260625/26692901.html http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CorMedix+Inc.++++++++++++++++++++++++/26692901.html Thu, 25 Jun 2026 16:36:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 23 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+23/26685958.html si-local-file:///var/storage/secattach/20260624/26685958.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+23/26685958.html Wed, 24 Jun 2026 16:31:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 23 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+23/26685958.html si-local-file:///var/storage/secattach/20260624/26685958.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+23/26685958.html Wed, 24 Jun 2026 16:31:00 -0400 CRMD O.08513169 Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html si-local-file:///var/storage/secattach/20260612/26639909.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html Fri, 12 Jun 2026 13:24:00 -0400 CRMD O.08513169 Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html si-local-file:///var/storage/secattach/20260612/26639909.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html Fri, 12 Jun 2026 13:24:00 -0400 CRMD O.08513169 Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html si-local-file:///var/storage/secattach/20260612/26639857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html Fri, 12 Jun 2026 13:07:00 -0400 CRMD O.08513169 Form SCHEDULE 13G/A CorMedix Inc. Filed by: SHAIBATALHAMD AYMEN ABDALKADER http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html si-local-file:///var/storage/secattach/20260612/26639857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html Fri, 12 Jun 2026 13:07:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 08 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html si-local-file:///var/storage/secattach/20260608/26614889.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html Mon, 08 Jun 2026 08:45:00 -0400 CRMD O.08513169 Form 8-K CorMedix Inc. For: Jun 08 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html si-local-file:///var/storage/secattach/20260608/26614889.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html Mon, 08 Jun 2026 08:45:00 -0400 CRMD O.08513169 CorMedix wins federal appeals court ruling on Minocin patent case http://www.streetinsider.com/Litigation/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html <p>The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that upholds CorMedix Therapeutics' (NASDAQ: CRMD) patents for Minocin for Injection and finds Nexus Pharmaceuticals infringed those patents.</p><p>The Federal Circuit decision upheld a 2023 district court ruling from the U.S. District Court for the Northern District of Illinois following a four-day bench trial. The lower court had found in favor of CorMedix's subsidiary Melinta Therapeutics on patent infringement and validity issues.</p><p>The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the http://www.streetinsider.com/Litigation/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html Mon, 08 Jun 2026 08:32:40 -0400 CRMD CorMedix wins federal appeals court ruling on Minocin patent case http://www.streetinsider.com/Corporate+News/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html <p>The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that upholds CorMedix Therapeutics' (NASDAQ: CRMD) patents for Minocin for Injection and finds Nexus Pharmaceuticals infringed those patents.</p><p>The Federal Circuit decision upheld a 2023 district court ruling from the U.S. District Court for the Northern District of Illinois following a four-day bench trial. The lower court had found in favor of CorMedix's subsidiary Melinta Therapeutics on patent infringement and validity issues.</p><p>The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the http://www.streetinsider.com/Corporate+News/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html Mon, 08 Jun 2026 08:32:40 -0400 CRMD U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100